fetal fibronectin is a glycoprotein that, when absent in cervicovaginal secretions between 24-34 weeks gestation, indicates that a woman is unlikely to give birth within the next 7-14 day (1)
test, using a vaginal swab, is easy to perform and test results are rapidly available
Notes:
fetal fibronectin
presence of fetal fibronectin is an effective biochemical marker for predicting preterm birth
a stable glycoprotein produced by the fetal membranes, adheres the fetal membranes and placenta to the uterine lining and plays a critical role in facilitating the physiological separation of the placenta from the uterus after delivery
generally not present at levels >50 ng/mL between 16 and 22 weeks of gestation, earlier studies have shown that its presence (>50 ng/mL) in the cervix or vagina from 22 weeks of gestation and beyond is a powerful predictor of subsequent spontaneous preterm birth (2,3)
NICE state (4)
fetal fibronectin testing should be considered as a diagnostic test to determine likelihood of birth within 48 hours for women who are 30+0 weeks pregnant or more if transvaginal ultrasound measurement of cervical length is indicated but is not available or not acceptable. Act on the results as follows:
if fetal fibronectin testing is negative (concentration 50 ng/ml or less), explain to the woman that it is unlikely that she is in preterm labour and:
think about alternative diagnoses
discuss with her the benefits and risks of going home compared with continued monitoring and treatment in hospital
advise her that if she does decide to go home, she should return if symptoms suggestive of preterm labour persist or recur
if fetal fibronectin testing is positive (concentration more than 50 ng/ml), view the woman as being in diagnosed preterm labour and offer treatment measures for preterm labour (tocolysis, maternal corticosteroids)
Goldenberg RL, Klebanoff M, Carey JC, et al. Vaginal fetal fibronectin measurements from 8 to 22 weeks' gestation and subsequent spontaneous preterm birth. American Journal of Obstetrics and Gynecology. 2000;183(2):469-475.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.